STEGLATRO

This brand name is authorized in Austria, Australia, Cyprus, Estonia, Spain, Finland, Hong Kong, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States

Active ingredients

The drug STEGLATRO contains one active pharmaceutical ingredient (API):

1 Ertugliflozin L-pyroglutamic acid UNII MLU731K321 - ERTUGLIFLOZIN PIDOLATE

Ertugliflozin helps to lower blood glucose by making the patient pass out glucose in the urine. It does this by blocking a protein in the kidneys (called SGLT2) that normally takes glucose back into the blood from the kidneys. Read about Ertugliflozin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STEGLATRO Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BK04		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Discover more medicines within A10BK04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11570Y, 11571B, 11577H, 11585R
Country: EE	Ravimiamet	Identifier(s): 1767472, 1767483, 1767494, 1767506, 1767517, 1767528, 1767539, 1767540, 1767551, 1767562, 1778913, 1778924
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181267002, 1181267008
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 199903, 485799, 491257, 531382
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 365149, 365152
Country: HK	Department of Health Drug Office	Identifier(s): 66203, 66204
Country: IE	Health Products Regulatory Authority	Identifier(s): 27573, 27698
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8311, 8456
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085283, 1085284, 1085285, 1085286, 1085287, 1085288, 1085289, 1085290, 1085291, 1085292, 1085293, 1085294, 1087677, 1087678
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 167665, 167673
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100405521, 100405538
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66525001, W66525002, W66525003, W66525004, W66526001, W66526002, W66526003, W66526004
Country: US	FDA, National Drug Code	Identifier(s): 0006-5363, 0006-5364